Heavy Alcohol Intake Linked to Obesity, Type 2 Diabetes

THURSDAY, July 6, 2023 (HealthDay News) -- Heavy alcohol intake is associated with increased measures of obesity and type 2 diabetes, according to a study published online June 27 in the Journal of Clinical Endocrinology & Metabolism.
Tianyuan Lu, Ph.D., from the Jewish General Hospital in Montreal, and colleagues examined the dose-dependent effect of alcohol consumption on obesity and type 2 diabetes among 408,540 participants of European ancestry in the U.K. Biobank. Mendelian randomization (MR) analyses were conducted in the overall population and in subgroups stratified by alcohol intake frequency.
The researchers found that a one-drink-per-week increase in genetically predicted alcohol intake frequency was associated with a 0.36-kg increase in fat mass, a 1.08-fold increase in the odds of obesity, and a 1.10-fold increase in the odds of type 2 diabetes among individuals having more than 14 drinks a week. Stronger associations were seen in women than men. Among individuals having seven or fewer drinks per week, there was no evidence found to support the association between genetically increased alcohol intake frequency and improved health outcomes, with MR estimates largely overlapping the null. The results were robust to multiple sensitivity analyses assessing the validity of MR assumptions.
"Some research has indicated that moderate drinkers may be less likely to develop obesity or diabetes compared to nondrinkers and heavy drinkers," Lu said in a statement. "However, our study shows that even light-to-moderate alcohol consumption (no more than one standard drink per day) does not protect against obesity and type 2 diabetes in the general population."
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Related Posts
RSVpreF Safe, Effective for Preventing Respiratory Syncytial Virus Illness in Seniors
MONDAY, April 10, 2023 (HealthDay News) -- The respiratory syncytial virus...
First Biosimilar Approved for Macular Degeneration, Other Eye Conditions
THURSDAY, Sept. 23, 2021 (HealthDay News) -- The first biosimilar to Lucentis...
Massachusetts Man Has Monkeypox, Following Clusters in Europe
THURSDAY, May 19, 2022 (HealthDay News) -- The first U.S. case this year of a...
‘Breakthrough’ Infections After COVID Vaccine Can Help Prevent Future Illness
WEDNESDAY, Sept. 28, 2022 (HealthDay News) -- It's very frustrating to get a...
